Capecitabine metronomic chemotherapy for metastatic colorectal cancer patients reaching NED: A protocol for a prospective, randomized, controlled trial.

Capecitabine metronomic chemotherapy for metastatic colorectal cancer patients reaching NED: A protocol for a prospective, randomized, controlled trial.

<h4>Introduction</h4>An increasing number of patients with metastatic colorectal cancer (mCRC) have achieved no evidence of diseases (NED) status after surgery or other treatments. However, the latest guidelines for colorectal cancer do not recommend an appropriate treatment for patients...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiaming Wu, Yu Dong, Wanshan Zhu, Jincheng Meng, Huatang Zhang, Cantu Fang, Lizhu Lin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0320591
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items